posted on 2021-03-25, 08:35authored byAnna Lusakowska, Maria Jedrzejowska, Anna Kaminska, Katarzyna Janiszewska, Przemysław Grochowski, Janusz Zimowski, Janusz Sierdzinski, Anna Kostera-Pruszczyk
Additional file 2. Probability of being able to walk after the indicated disease durations disease for patients with SMA3 and three or four copies of SMN2 separately, and by SMA3a (age of onset < 3 years) and SMA3b (age of onset ≥ 3 years).